Ventas Inc. Stock
Ventas Inc. Stock
The Ventas Inc. stock is trending slightly upwards today, with an increase of €0.64 (0.860%) compared to yesterday's price.
With 19 Buy predictions and not the single Sell prediction the community is currently very high on Ventas Inc..
With a current price of 75.8 € Ventas Inc. is right around the predicted target price of 76 €.
So far the community has only identified positive things for Ventas Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Ventas Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ventas Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ventas Inc. | 0.860% | 3.495% | 5.600% | 23.978% | 11.998% | 80.433% | 61.638% |
| Host Hotels & Resorts Inc | -0.600% | -3.550% | -2.976% | 17.266% | 3.165% | 10.884% | 12.414% |
| Weyerhaeuser Co. | 2.750% | -2.890% | -8.970% | -23.221% | 1.889% | -27.085% | -31.712% |
| Public Storage | 0.770% | -1.808% | 3.043% | -3.444% | 18.285% | -3.427% | 30.900% |
Comments
Ventas (VTR) had its price target raised by Mizuho from $87.00 to $94.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) was given a new $91.00 price target on by analysts at Royal Bank Of Canada. They now have an "outperform" rating on the stock.
Show more
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) had its price target raised by analysts at KeyCorp from $85.00 to $90.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for VTR provided by MarketBeat
News
Prediction: These Could Be the Best-Performing Healthcare Dividend Stocks Through 2030
There are times when unexpected global events have an outsized impact on a company's business. That was true across a broad spectrum of stocks after the coronavirus pandemic began. But at the center
